Last 12 months
Inside the activity.
0 purchase rows · 19 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 8 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 05, 2019 Filed Dec 9, 2019 21:55 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 100 | $185.02 | $18,502.00 |
DisclosureSEC source: 0001073397-19-000006 · edgardoc.xml · nonDerivative · entry 3 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 348,864 F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| December 05, 2019 Filed Dec 9, 2019 21:55 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 12,839 | $184.23 | $2,365,323.83 |
DisclosureSEC source: 0001073397-19-000006 · edgardoc.xml · nonDerivative · entry 2 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 348,964 F1 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $184.00 to $184.96, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| December 05, 2019 Filed Dec 9, 2019 21:55 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
OtherCommon Stock | 12,939 | $43.62 | $564,399.18 |
DisclosureSEC source: 0001073397-19-000006 · edgardoc.xml · nonDerivative · entry 1 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,803 Read SEC document |
| December 03, 2019 Filed Dec 3, 2019 23:21 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 20,000 | $43.62 Strike: $43.62 | $872,400.00 |
DisclosureSEC source: 0001073397-19-000004 · edgardoc.xml · derivative · entry 5 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2021-07-20 F3 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| December 03, 2019 Filed Dec 3, 2019 23:21 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 6,522 | $184.78 | $1,205,124.07 |
DisclosureSEC source: 0001073397-19-000004 · edgardoc.xml · nonDerivative · entry 3 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 348,864 F2 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $184.63 to $185.24, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| December 03, 2019 Filed Dec 3, 2019 23:21 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 13,478 | $184.06 | $2,480,706.77 |
DisclosureSEC source: 0001073397-19-000004 · edgardoc.xml · nonDerivative · entry 2 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,386 F1 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $183.63 to $184.62, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| December 03, 2019 Filed Dec 3, 2019 23:21 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
OtherCommon Stock | 20,000 | $43.62 | $872,400.00 |
DisclosureSEC source: 0001073397-19-000004 · edgardoc.xml · nonDerivative · entry 1 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,864 Read SEC document |
| October 14, 2019 Filed Oct 15, 2019 16:28 UTC |
SWINNEY ROBERT SDirector
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 1,500 | $0.00 Strike: $37.36 | $0.00 |
DisclosureSEC source: 0001073398-19-000014 · edgardoc.xml · derivative · entry 4 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2019-10-21 F3 · derivative.exercise_date: These stock options vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| October 14, 2019 Filed Oct 15, 2019 16:28 UTC |
SWINNEY ROBERT SDirector
|
SaleCommon Stock | 373 | $153.49 | $57,251.77 |
DisclosureSEC source: 0001073398-19-000014 · edgardoc.xml · nonDerivative · entry 2 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,472 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2018. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| October 14, 2019 Filed Oct 15, 2019 16:28 UTC |
SWINNEY ROBERT SDirector
|
OtherCommon Stock | 1,500 | $37.36 | $56,040.00 |
DisclosureSEC source: 0001073398-19-000014 · edgardoc.xml · nonDerivative · entry 1 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,845 Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 19:39 UTC |
Sanzone Virginia RuthVP, General Counsel
|
SaleCommon Stock | 3,000 | $154.08 | $462,240.60 |
DisclosureSEC source: 0001669639-19-000011 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.07 to $154.24 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 01, 2019 Filed Sep 4, 2019 15:41 UTC |
McGrody Kevin JChief Accounting Officer
|
Exercise / conversionCommon Stock · Derivative | 571 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001615192-19-000010 · edgardoc.xml · derivative · entry 3 McGrody Kevin J · CIK 0001615192 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 572 Underlying: Common Stock · 571 shares Expires 2020-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| September 01, 2019 Filed Sep 4, 2019 15:41 UTC |
McGrody Kevin JChief Accounting Officer
|
Tax withholdingCommon Stock | 284 | $0.00 | $0.00 |
DisclosureSEC source: 0001615192-19-000010 · edgardoc.xml · nonDerivative · entry 2 McGrody Kevin J · CIK 0001615192 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 955 Read SEC document |
| September 01, 2019 Filed Sep 4, 2019 15:41 UTC |
McGrody Kevin JChief Accounting Officer
|
Exercise / conversionCommon Stock | 571 | $0.00 | $0.00 |
DisclosureSEC source: 0001615192-19-000010 · edgardoc.xml · nonDerivative · entry 1 McGrody Kevin J · CIK 0001615192 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,239 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| August 15, 2019 Filed Aug 15, 2019 22:08 UTC |
SWINNEY ROBERT SDirector
|
SaleCommon Stock | 2,078 | $165.18 | $343,244.04 |
DisclosureSEC source: 0001073398-19-000012 · edgardoc.xml · nonDerivative · entry 1 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,345 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on November 26, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.08 to $165.18 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| July 15, 2019 Filed Jul 15, 2019 22:58 UTC |
SWINNEY ROBERT SDirector
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 1,500 | $0.00 Strike: $38.85 | $0.00 |
DisclosureSEC source: 0001073398-19-000010 · edgardoc.xml · derivative · entry 4 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2019-07-22 F3 · derivative.exercise_date: These stock options vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| July 15, 2019 Filed Jul 15, 2019 22:58 UTC |
SWINNEY ROBERT SDirector
|
SaleCommon Stock | 239 | $248.73 | $59,446.47 |
DisclosureSEC source: 0001073398-19-000010 · edgardoc.xml · nonDerivative · entry 2 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,423 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2018. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| July 15, 2019 Filed Jul 15, 2019 22:58 UTC |
SWINNEY ROBERT SDirector
|
OtherCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001073398-19-000010 · edgardoc.xml · nonDerivative · entry 1 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,662 Read SEC document |
| June 26, 2019 Filed Jun 26, 2019 21:37 UTC |
Lamb Scott EChief Financial Officer,
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 3,325 | $58.79 Strike: $58.79 | $195,476.75 |
DisclosureSEC source: 0001375852-19-000009 · edgardoc.xml · derivative · entry 6 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 3,325 shares Expires 2024-02-24 F4 · price: Transaction is the exercise of a derivative security; see Column 2. F3 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the grant date . Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days. Read SEC document |
| June 26, 2019 Filed Jun 26, 2019 21:37 UTC |
Lamb Scott EChief Financial Officer,
|
SaleCommon Stock | 3,325 | $250.00 | $831,250.00 |
DisclosureSEC source: 0001375852-19-000009 · edgardoc.xml · nonDerivative · entry 4 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,309 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 11, 2019. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| June 26, 2019 Filed Jun 26, 2019 21:37 UTC |
Lamb Scott EChief Financial Officer,
|
OtherCommon Stock | 3,325 | $58.79 | $195,476.75 |
DisclosureSEC source: 0001375852-19-000009 · edgardoc.xml · nonDerivative · entry 3 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,634 Read SEC document |
| June 25, 2019 Filed Jun 26, 2019 21:37 UTC |
Lamb Scott EChief Financial Officer,
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 21,675 | $58.79 Strike: $58.79 | $1,274,273.25 |
DisclosureSEC source: 0001375852-19-000009 · edgardoc.xml · derivative · entry 5 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,325 Underlying: Common Stock · 21,675 shares Expires 2024-02-24 F4 · price: Transaction is the exercise of a derivative security; see Column 2. F3 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the grant date . Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days. Read SEC document |
| June 25, 2019 Filed Jun 26, 2019 21:37 UTC |
Lamb Scott EChief Financial Officer,
|
SaleCommon Stock | 21,675 | $250.00 | $5,418,750.00 |
DisclosureSEC source: 0001375852-19-000009 · edgardoc.xml · nonDerivative · entry 2 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,309 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 11, 2019. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| June 25, 2019 Filed Jun 26, 2019 21:37 UTC |
Lamb Scott EChief Financial Officer,
|
OtherCommon Stock | 21,675 | $58.79 | $1,274,273.25 |
DisclosureSEC source: 0001375852-19-000009 · edgardoc.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,984 Read SEC document |
| June 10, 2019 Filed Jun 11, 2019 20:24 UTC |
McGrody Kevin JController
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 438 | $61.76 Strike: $61.76 | $27,050.88 |
DisclosureSEC source: 0001615192-19-000008 · edgardoc.xml · derivative · entry 7 McGrody Kevin J · CIK 0001615192 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 438 shares Expires 2023-02-06 F5 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| June 10, 2019 Filed Jun 11, 2019 20:24 UTC |
McGrody Kevin JController
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 3,805 | $58.79 Strike: $58.79 | $223,695.95 |
DisclosureSEC source: 0001615192-19-000008 · edgardoc.xml · derivative · entry 6 McGrody Kevin J · CIK 0001615192 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,805 shares Expires 2024-02-24 F5 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| June 10, 2019 Filed Jun 11, 2019 20:24 UTC |
McGrody Kevin JController
|
SaleCommon Stock | 4,243 | $231.89 | $983,909.27 |
DisclosureSEC source: 0001615192-19-000008 · edgardoc.xml · nonDerivative · entry 5 McGrody Kevin J · CIK 0001615192 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 668 F4 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| June 10, 2019 Filed Jun 11, 2019 20:24 UTC |
McGrody Kevin JController
|
SaleCommon Stock | 82 | $231.95 | $19,019.90 |
DisclosureSEC source: 0001615192-19-000008 · edgardoc.xml · nonDerivative · entry 4 McGrody Kevin J · CIK 0001615192 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,911 F3 · shares: Shares were previously acquired through the Registrant's Employee Stock Purchase Plan. F4 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| June 10, 2019 Filed Jun 11, 2019 20:24 UTC |
McGrody Kevin JController
|
SaleCommon Stock | 3,019 | $231.37 | $698,506.03 |
DisclosureSEC source: 0001615192-19-000008 · edgardoc.xml · nonDerivative · entry 3 McGrody Kevin J · CIK 0001615192 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,993 F1 · shares: These securities are vested Restricted Stock Units. F2 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $231.23 to $231.75, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 10, 2019 Filed Jun 11, 2019 20:24 UTC |
McGrody Kevin JController
|
OtherCommon Stock | 438 | $61.76 | $27,050.88 |
DisclosureSEC source: 0001615192-19-000008 · edgardoc.xml · nonDerivative · entry 2 McGrody Kevin J · CIK 0001615192 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,012 Read SEC document |
| June 10, 2019 Filed Jun 11, 2019 20:24 UTC |
McGrody Kevin JController
|
OtherCommon Stock | 3,805 | $58.79 | $223,695.95 |
DisclosureSEC source: 0001615192-19-000008 · edgardoc.xml · nonDerivative · entry 1 McGrody Kevin J · CIK 0001615192 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,574 Read SEC document |
| May 22, 2019 Filed May 28, 2019 22:32 UTC |
Jain VivekDirector · Chairman and CEO
|
GiftCommon Stock | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-19-000008 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,945 F1 · price: Shares transferred as a bona fide gift without any consideration. Read SEC document |
| May 15, 2019 Filed May 16, 2019 16:19 UTC |
Greenberg David C.Director
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 1,253 | $0.00 Strike: $225.27 | $0.00 |
DisclosureSEC source: 0001645866-19-000002 · edgardoc.xml · derivative · entry 5 Greenberg David C. · CIK 0001645866 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,253 Underlying: Common Stock · 1,253 shares Expires 2029-05-15 Read SEC document |
| May 15, 2019 Filed May 16, 2019 16:19 UTC |
Greenberg David C.Director
|
GrantCommon Stock · Derivative | 378 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001645866-19-000002 · edgardoc.xml · derivative · entry 4 Greenberg David C. · CIK 0001645866 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 378 Underlying: Common Stock · 378 shares Expires 2020-05-15 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award. Read SEC document |
| May 15, 2019 Filed May 16, 2019 16:19 UTC |
Greenberg David C.Director
|
Exercise / conversionCommon Stock · Derivative | 315 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001645866-19-000002 · edgardoc.xml · derivative · entry 3 Greenberg David C. · CIK 0001645866 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 315 shares Expires 2019-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award. Read SEC document |
| May 15, 2019 Filed May 16, 2019 16:19 UTC |
Greenberg David C.Director
|
Exercise / conversionCommon Stock | 315 | $0.00 | $0.00 |
DisclosureSEC source: 0001645866-19-000002 · edgardoc.xml · nonDerivative · entry 1 Greenberg David C. · CIK 0001645866 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2019 Filed May 16, 2019 16:46 UTC |
FINNEY ELISHA WDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 1,253 | $0.00 Strike: $225.27 | $0.00 |
DisclosureSEC source: 0001209191-19-030253 · doc4.xml · derivative · entry 4 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,253 Underlying: Common Stock · 1,253 shares Expires 2029-05-15 Read SEC document |
| May 15, 2019 Filed May 16, 2019 16:46 UTC |
FINNEY ELISHA WDirector
|
GrantCommon Stock · Derivative | 378 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-030253 · doc4.xml · derivative · entry 3 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 378 Underlying: Common Stock · 378 shares Expires 2020-05-15 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award. Read SEC document |
| May 15, 2019 Filed May 16, 2019 16:46 UTC |
FINNEY ELISHA WDirector
|
Exercise / conversionCommon Stock · Derivative | 315 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-030253 · doc4.xml · derivative · entry 2 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 315 shares Expires 2019-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award. Read SEC document |
| May 15, 2019 Filed May 16, 2019 16:46 UTC |
FINNEY ELISHA WDirector
|
Exercise / conversionCommon Stock | 315 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-030253 · doc4.xml · nonDerivative · entry 1 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2019 Filed May 16, 2019 16:29 UTC |
Abbey DonaldDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 1,253 | $0.00 Strike: $225.27 | $0.00 |
DisclosureSEC source: 0001209191-19-030246 · doc4.xml · derivative · entry 4 Abbey Donald · CIK 0001534342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,253 Underlying: Common Stock · 1,253 shares Expires 2029-05-15 Read SEC document |
| May 15, 2019 Filed May 16, 2019 16:29 UTC |
Abbey DonaldDirector
|
GrantCommon Stock · Derivative | 378 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-030246 · doc4.xml · derivative · entry 3 Abbey Donald · CIK 0001534342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 378 Underlying: Common Stock · 378 shares Expires 2020-05-15 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award. Read SEC document |
| May 15, 2019 Filed May 16, 2019 16:29 UTC |
Abbey DonaldDirector
|
Exercise / conversionCommon Stock · Derivative | 315 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-030246 · doc4.xml · derivative · entry 2 Abbey Donald · CIK 0001534342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 315 shares Expires 2019-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award. Read SEC document |
| May 15, 2019 Filed May 16, 2019 16:29 UTC |
Abbey DonaldDirector
|
Exercise / conversionCommon Stock | 315 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-030246 · doc4.xml · nonDerivative · entry 1 Abbey Donald · CIK 0001534342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2019 Filed May 16, 2019 16:42 UTC |
Hoffmeister David FDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 1,253 | $0.00 Strike: $225.27 | $0.00 |
DisclosureSEC source: 0001209191-19-030250 · doc4.xml · derivative · entry 4 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,253 Underlying: Common Stock · 1,253 shares Expires 2029-05-15 Read SEC document |
| May 15, 2019 Filed May 16, 2019 16:42 UTC |
Hoffmeister David FDirector
|
GrantCommon Stock · Derivative | 378 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-030250 · doc4.xml · derivative · entry 3 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 378 Underlying: Common Stock · 378 shares Expires 2020-05-15 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award. Read SEC document |
| May 15, 2019 Filed May 16, 2019 16:42 UTC |
Hoffmeister David FDirector
|
Exercise / conversionCommon Stock · Derivative | 315 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-030250 · doc4.xml · derivative · entry 2 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 315 shares Expires 2019-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award. Read SEC document |
| May 15, 2019 Filed May 16, 2019 16:42 UTC |
Hoffmeister David FDirector
|
Exercise / conversionCommon Stock | 315 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-030250 · doc4.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2019 Filed May 16, 2019 16:18 UTC |
SWINNEY ROBERT SDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 1,253 | $0.00 Strike: $225.27 | $0.00 |
DisclosureSEC source: 0001073398-19-000008 · edgardoc.xml · derivative · entry 5 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,253 Underlying: Common Stock · 1,253 shares Expires 2029-05-15 Read SEC document |
| May 15, 2019 Filed May 16, 2019 16:18 UTC |
SWINNEY ROBERT SDirector
|
GrantCommon Stock · Derivative | 378 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001073398-19-000008 · edgardoc.xml · derivative · entry 4 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 378 Underlying: Common Stock · 378 shares Expires 2020-05-15 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.